Press Releases Latest Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model Press Releases Year None20232022202120202019201820172016201520142013 Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model Mar 07, 2023 Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price Feb 28, 2023 Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022 Feb 28, 2023 Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management Feb 22, 2023 Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV Feb 16, 2023 Theratechnologies Announces Path to Resume TH1902 Clinical Development Feb 14, 2023 Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update Jan 04, 2023 Open Letter to Shareholders from CEO Paul Levesque Dec 01, 2022 Theratechnologies Announces Update from Ongoing TH1902 Study Oct 26, 2022 Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 305
Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Mar 14, 2023 Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
Feb 28, 2023 Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
Feb 28, 2023 Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
Feb 22, 2023 Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
Feb 14, 2023 Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
Oct 26, 2022 Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays